| http://www.w3.org/ns/prov#value | - This Phase 1b clinical trial will determine if the FDA-approved antihypertensive drug, perindopril, may work by mechanisms other than lowering blood pressure to ultimately reduce Alzheimer???s risk in African-Americans with a family history of Alzheimer???s disease. 2013 Grant Recipients
|
